Runtime 31:17
London South East were delighted to welcome Incanthera to our April Investor Webinar last night (6.04.2021), where Chairman Tim McCarthy and CEO Dr Simon Ward presented and took questions.
Incanthera are an AQSE-listed oncology and dermatology therapy business with close ties to the University of Bradford cancer therapy labs. They develop and licence innovative technologies for the treatment of cancer and skin cancer.
They recently raised 1.14M from an oversubscribed share placing which is intended to see them through lucrative commercial negotiations with two global cosmetic companies as they agree licensing arrangements for their innovative anti-skin cancer cream Sol.
By quickly commercialising Sol, they hope to create a regular revenue stream to develop the business as they work on a significant pipeline of other cancer treatments.
Runtime 29:09
Graham Clarke CEO and Andrew Vaughan, Head of Corporate Development from Emmerson (LSE:EML) the Moroccan potash mine developer, presented at London South East s April Investor Webinar, 06.04.2021.
After a detailed presentation the management team took questions.
As you may know, the Khemisset low cost and high margin mine project is situated in Northern Morocco close to a major sea port for easy transportation.
The mine has a 19 year life potential, and there is scope to double this to 38 years Graham explained during the Q&A.
The possibility of an adding an extra site or SOP was discussed at 03:36?. Graham said that it stands out as a huge opportunity because it is close to the port of Jorf Lasfar which has a ready supply of sulphuric acid to make a higher margin potash product. This makes it a fairly unique location for an SOP project.